Otolaryngology · Sugar Land, TX
NPI
1750603700
Since 2010
Specialty
Otolaryngology
Code 207Y00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
16545 Southwest Fwy, Suite 100
Sugar Land, TX, 77479
Phone (281) 649-7200
Groups this clinician bills Medicare through
Medicare paid, 2024
$391K
1,922 services
Medicare patients, 2024
297
Average age 73
Drug cost, 2024
$67K
1,044 prescriptions
Company payments, 2025
$34K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pavlina P Suchanova was code 31231 (nasal/sinus endoscopy), 569 times for 253 patients. In total Pavlina P Suchanova billed 1,922 services in 42 codes, and Medicare paid $391K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-10-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 31231 Nasal/Sinus Endoscopy | Office | 569 | 253 | $133.39 | $76K |
| 99214 Office E&M - Established | Office | 473 | 216 | $87.91 | $42K |
| 99204 Office E&M - New | Office | 115 | 115 | $116.55 | $13K |
| 31237 Nasal/Sinus Endoscopy | Office | 109 | 57 | $279.90 | $31K |
| 95117 Treatment - Miscellaneous | Office | 98 | 26 | $8.19 | $802 |
| 30117 Other Organ Systems | Office | 86 | 41 | $368.34 | $32K |
| 70486 CT/CTA - Head and Neck | Office | 66 | 66 | $96.64 | $6,378 |
| 69210 Other Organ Systems | Office | 65 | 46 | $18.69 | $1,215 |
| 30802 Other Organ Systems | Office | 34 | 34 | $104.64 | $3,558 |
| 31242 Nasal/Sinus Endoscopy | Office | 32 | 32 | $1,852.30 | $59K |
| G0268 Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 21 | 21 | $20.25 | $425 |
| 92653 Test - Miscellaneous | Office | 18 | 18 | $62.90 | $1,132 |
| 92584 Test - Miscellaneous | Office | 18 | 18 | $83.30 | $1,499 |
| 92546 Vision, Hearing, and Speech Services | Office | 16 | 16 | $82.61 | $1,322 |
| 92537 Test - Miscellaneous | Office | 16 | 16 | $30.20 | $483 |
By year: 2022 $200K for 1,137 services; 2023 $251K for 1,586 services; 2024 $391K for 1,922 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pavlina P Suchanova prescribed most often to Medicare patients was Omeprazole, with 167 prescriptions and refills. In total Pavlina P Suchanova wrote 1,044 Medicare prescriptions that cost $67K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 167 | 272 | 82 | $1,422 |
| Doxycycline Hyclate Generic | 137 | 137 | 119 | $1,610 |
| Methylprednisolone Generic | 133 | 133 | 108 | $866 |
| Budesonide Generic | 67 | 107 | 23 | $6,836 |
| Ryaltris Olopatadine Hcl/Mometasone | 52 | 58 | 24 | $14K |
| Famotidine Generic | 51 | 74 | 25 | $334 |
| Ipratropium Bromide Generic | 49 | 49 | 22 | $987 |
| Mupirocin Generic | 44 | 44 | 42 | $284 |
| Xhance Fluticasone Propionate | 41 | 55 | 11 | $31K |
| Fluticasone Propionate Generic | 34 | 46 | 15 | $423 |
| Azelastine Hcl Generic | 32 | 45 | 18 | $811 |
| Levofloxacin Generic | 30 | 30 | 29 | $145 |
| Prednisone Generic | 26 | 26 | 25 | $85.38 |
| Ciprofloxacin-Dexamethasone Ciprofloxacin Hcl/Dexameth | 26 | 26 | 25 | $3,293 |
| Ciprofloxacin Hcl Generic | 18 | 18 | 18 | $118 |
Brand drugs: 117 claims; generic drugs: 927 claims; opioid claims: 24.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pavlina P Suchanova $34K ($34K in general payments such as food, travel and fees) from 14 companies. The largest payer was Aerin Medical Inc. with $18K.
| Company | Payments | Amount |
|---|---|---|
| Aerin Medical Inc. | 15 | $18K |
| Optinose US, Inc. | 23 | $16K |
| ARS Pharmaceuticals Operations, Inc. SPRY | 7 | $223 |
| Grifols USA, LLC | 1 | $125 |
| Genzyme Corporation SNY | 3 | $92.78 |
| GlaxoSmithKline, LLC. GSK | 3 | $61.97 |
| CSL Behring CSL.AX | 3 | $59.98 |
| Medtronic, Inc. MDT | 2 | $51.02 |
| Paratek Pharmaceuticals, Inc. | 2 | $49.57 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $29.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.